Zobrazeno 1 - 2
of 2
pro vyhledávání: '"E.А. Krasavina"'
Autor:
N. D. Yushchuk, Jsc R-Pharm, S N Batskikh, K. V. Kozlov, N.A. Mamonova, D.A. Gusev, E.А. Krasavina, Svetlana Kizhlo, K. V. Zhdanov, Vasily Isakov, E.А. Klimova, Vladimir Chulanov, E.P. Tarkhova, M.Yu. Samsonov, V.S. Sukachev, O. O. Znoyko
Publikováno v:
Infectious diseases: News, Opinions, Training. 9:50-56
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59d06f4ea2f5eabccc66f90e2c09ae1e
https://doi.org/10.33029/2305-3496-2020-9-1-50-56
https://doi.org/10.33029/2305-3496-2020-9-1-50-56
Autor:
Nikolskaya M, Vafin A, Shults E, Razzhivina, Dmitrikova Ep, Otpushchennikova M, Rusanova M, Filon O, Garbuzov Aa, Kaplun E, Petina D, Domostroeva T, Samsonov M, Bistritskiy D, Lesina, Kostina N, Ruzhentsova T, Shestakova I, Oseshnyuk R, Chukhliaev P, Brook Y, Agafina A, Khavkina D, Scherbak S, Pokrovsky K, Mustafaev D, Soluyanova T, E.А. Krasavina, Bronov O, Markova Т, Zintchenko A
Publikováno v:
SSRN Electronic Journal.
Background: Favipiravir is an antiviral drug, an inhibitor of RNA dependent RNA polymerase that is preliminarily effective against SARS-CoV-2 virus. The aim of this study was to evaluate the efficacy and safety of favipiravir for treatment of mild to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5ef43b8e6fd7550750ea48ed43ab67c
https://doi.org/10.2139/ssrn.3696907
https://doi.org/10.2139/ssrn.3696907